Effect of Corynebacterium parvum in prevention and reversal of atrophy of the liver following portacaval shunt.
Since it has been demonstrated that the administration of Corynebacterium parvum is associated with increased hepatocyte proliferation in both normal and regenerating livers, it seemed appropriate to determine whether the use of this agent would affect the hepatic atrophy which occurs following end-to-side portacaval shunts. When administered at shunting, liver weight and liver deoxyribonucleic acid failed to decrease to the same extent as that occurring in untreated, shunted rats. An increase in liver deoxyribonucleic acid synthesis was observed following portacaval shunt only in treated rats. Corynebacterium parvum administration to portacaval shunt rats with livers demonstrating marked atrophy 15 to 18 days following shunting resulted in the reversal of such atrophy. There was an increase in liver weight and deoxyribonuclei acid to the extent that those values were equal to, or greater than, those of livers from nonshunted rats. By increasing the number of cells within liver, Corynebacterium parvum administration prevents or reverses the decrease in liver size, that is, atrophy, which occurs after portacaval shunts were performed.
D000818:Animals; D001284:Atrophy / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D004247:DNA / Q000096:biosynthesis; D005260:Female; D008099:Liver / Q000378:metabolism / Q000473:pathology*; D009929:Organ Size; D011167:Portacaval Shunt, Surgical; D011183:Postoperative Complications / Q000517:prevention & control* / Q000628:therapy; D011425:Propionibacterium acnes; D051381:Rats
D004247:DNA